In February 2023, , a prominent health law professor and member of Canada's Patented Medicine Prices Review Board (PMPRB) , resigned in protest of what he described as the federal government's failure to support meaningful drug pricing reforms. His resignation highlighted a period of significant turmoil within the arms-length regulator, which is tasked with ensuring that patented medicine prices in Canada are not "excessive". Core Reasons for Resignation
: He claimed the Minister's office fundamentally undermined the board's independence by requesting a suspension of public consultations on new pricing guidelines. Herder noted these requests were "largely indistinguishable in form and substance from industry talking points". In February 2023, , a prominent health law
: Herder accused the Liberal government of lacking the "political courage" to stand by its own reform agenda, specifically by repeatedly delaying new regulations intended to lower drug costs. In February 2023